• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. BD TUBE MGIT 25 EA; SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. BD TUBE MGIT 25 EA; SYSTEM, BLOOD CULTURING Back to Search Results
Catalog Number 245111
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 02/28/2020
Event Type  Death  
Manufacturer Narrative
A device evaluation and/ or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
The customer reported that while using bd tube mgit 25 ea they noticed possible contamination.A patient death was reported.No information given suggests that the patient death was related to the device used.
 
Manufacturer Narrative
The following fields were modified with corrections: d.1.Medical device brand name: bd tube mgit 25 ea.D.2.Medical device type of device: mdb; common device name: system, blood culturing.
 
Event Description
The customer reported that while using bd tube mgit 25 ea they noticed possible contamination.A patient death was reported.No information given suggests that the patient death was related to the device used.
 
Manufacturer Narrative
H.6.Investigation summary: this product is manufactured by re-hydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.The batch history record review for batch 9267730 was satisfactory and no notifications were generated during manufacturing and inspection.Formulation and filling processes were within specifications.Qc inspection and testing were satisfactory at time of release.As part of the release criteria for this product, the bhr is reviewed to confirm the following: the total elapsed time between end of formulation and start of the autoclave cycle was within the specified limits.All autoclave parameters conformed to the validated cycle parameters for this product.The minimum f0 for this product was met.The complaint history was reviewed and the only other complaint taken on this batch was also from this customer for contamination.Retention samples from batch 9267730 (100 tubes) were available for inspection.One tube had a loose cap but no other cap, tube or media defects were observed in the other 99 retention tubes.M.Kansasii atcc 12478 is one of the organisms tested in the standard performance protocol for material 245111.During qc testing of batch 9267730, atcc 12478 had satisfactory growth within the specification of 11 days incubation at 36 to 38 degrees.For investigation, retention tubes from batch 9267730 were incubated at 33 to 37 degrees c (10 tubes) and 36 to 38 degrees c (10 tubes).No microbial growth or changes were observed in 20/20 retention tubes at 13 days incubation.No returns or photos were received for investigation.Bd will continue to trend complaints for contamination.This complaint cannot be confirmed.
 
Event Description
The customer reported that while using bd tube mgit 25 ea they noticed possible contamination.A patient death was reported.No information given suggests that the patient death was related to the device used.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD TUBE MGIT 25 EA
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON, DICKINSON & CO.
7 loveton circle
sparks MD 21152
MDR Report Key10094180
MDR Text Key192352988
Report Number1119779-2020-00118
Device Sequence Number1
Product Code MDB
UDI-Device Identifier00382902451112
UDI-Public00382902451112
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup,Followup
Report Date 06/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/18/2020
Device Catalogue Number245111
Device Lot Number9267730
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/05/2020
Initial Date FDA Received05/27/2020
Supplement Dates Manufacturer Received05/05/2020
05/05/2020
Supplement Dates FDA Received05/29/2020
06/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
-
-